Functional precision medicine in leukemias: current applications, challenges, and future directions

Functional precision medicine represents a promising approach to address the biological heterogeneity and therapeutic complexity of leukemias. By integrating direct functional assessment of drug response with molecular and clinical information, this strategy provides a more comprehensive framework for individualized therapy selection. Although important challenges remain, including methodological standardization, limited viability of primary leukemic cells, high infrastructure costs, and the need for prospective clinical validation, ongoing technological and computational advances are expected to facilitate broader clinical implementation. Ultimately, functional precision medicine may become a central component of modern hematologic oncology, enabling more dynamic, biologically informed, and patient-centered therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Medical Oncology
Published
2026-11-19
DOI
https://doi.org/10.1007/s12032-026-03563-5
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Functional precision medicine in leukemias: current applications, challenges, and future directions

Mateus Milani, José Andrés Yunes, Samara de Sousa Mariano
Medical Oncology
Acute Myeloid Leukemia Research
article

Functional precision medicine in leukemias: current applications, challenges, and future directions

Mateus Milani, José Andrés Yunes, Samara de Sousa Mariano
article en

Abstract

Functional precision medicine represents a promising approach to address the biological heterogeneity and therapeutic complexity of leukemias. By integrating direct functional assessment of drug response with molecular and clinical information, this strategy provides a more comprehensive framework for individualized therapy selection. Although important challenges remain, including methodological standardization, limited viability of primary leukemic cells, high infrastructure costs, and the need for prospective clinical validation, ongoing technological and computational advances are expected to facilitate broader clinical implementation. Ultimately, functional precision medicine may become a central component of modern hematologic oncology, enabling more dynamic, biologically informed, and patient-centered therapeutic strategies.

Medical OncologyVol. 43(12)
Universidade Estadual de Campinas (UNICAMP) (BR), Centro Infantil Boldrini (BR)
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon